- Home
- LAUR vs OPCH Comparison
LAUR vs OPCH Comparison
Compare LAUR & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAUR | OPCH |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Nursing Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.7B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LAUR | OPCH |
|---|---|---|
| Price | $33.38 | $31.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 11 |
| Target Price | ★ $41.50 | $30.03 |
| AVG Volume (30 Days) | 1.1M | ★ 6.5M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | ★ 1.54 | 0.64 |
| Revenue | $1,484,288,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $12.95 | $1.91 |
| Revenue Next Year | $6.80 | $6.41 |
| P/E Ratio | ★ $23.53 | $49.70 |
| Revenue Growth | ★ 19.48 | 16.17 |
| 52 Week Low | $24.98 | $18.01 |
| 52 Week High | $40.93 | $36.80 |
Technical Indicators
Market Signals| Indicator | LAUR | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 23.98 | 84.32 |
| Support Level | $33.20 | $28.70 |
| Resistance Level | $34.80 | $36.48 |
| Average True Range (ATR) | 1.23 | 0.12 |
| MACD | -0.60 | -0.15 |
| Stochastic Oscillator | 0.65 | 93.21 |
Price Performance
Historical ComparisonAbout LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its reportable segments include Peru and Mexico, of which Mexico derives maximum revenue. Geographically, the company operates in Mexico, Peru and United States.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.